Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 5/20 | 0.36 |
| ▸ | ESR1 | P03372 | 4/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | AGXT | P21549 | 2/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL780050 | 0.82 | APP (0.53) | APPPOLBNR4A2RXRARXRB | |
| SCHEMBL10601214 | 0.82 | ESR1 (0.48) | APPIDO1ESR1ESR2POLB | |
| SCHEMBL11308991 | 0.79 | APP (0.41) | APPIDO1ESR1ESR2POLB | |
| SCHEMBL18574373 | 0.79 | APP (0.36) | APPIDO1ESR1ESR2NR4A2 | |
| SCHEMBL10357375 | 0.78 | RORC (0.39) | APPIDO1ESR1ESR2POLB | |
| SCHEMBL12421573 | 0.78 | ESR1 (0.41) | APPIDO1ESR1ESR2POLB | |
| SCHEMBL134443 | 0.78 | IDO1 (0.46) | APPIDO1AGXTPTGS2 | |
| SCHEMBL10180151 | 0.77 | NPC1 (0.47) | APPESR1ESR2POLB | |
| SCHEMBL791859 | 0.76 | IDO1 (0.63) | IDO1KMT2A | |
| SCHEMBL26078639 | 0.75 | TSHR (0.40) | ESR1ESR2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815322-B2 | Metallocene supported catalyst and method for preparing polypropylene using the same | LG CHEM, LTD. (KR) | 2020-10-27 | — | — | US | disclosed |
| US-20190106516-A1 | Metallocene Supported Catalyst And Method For Preparing Polypropylene Using The Same | LG CHEM, LTD. (KR) | 2019-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815322-B2 | Metallocene supported catalyst and method for preparing polypropylene using the same | PPOX, PCNA, MUS81 | APP 2799/4885IDO1 2452/4885ESR1 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.